Differential expression of vascular endothelial growth factor in high- and low-metastasis cell lines of salivary gland adenoid cystic carcinoma

Anticancer Research

Volumn 34, Issue 2, 2014, Pages 671-678

  Kondo, Seiji ^a   Mukudai, Yoshiki ^a   Soga, Daisuke ^a   Nishida, Takashi ^b   Takigawa, Masaharu ^b,c   Shirota, Tatsuo ^a  

^a SHOWA UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

Adenoid cystic carcinoma; Hypoxia; Vascular endothelial growth factor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; HIF1A PROTEIN, HUMAN; MESSENGER RNA; TUMOR MARKER; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER CELL LINE; CANCER THERAPY; CONTROLLED STUDY; DISEASE MARKER; DISTANT METASTASIS; GENE OVEREXPRESSION; METASTASIS; PROTEIN EXPRESSION; SALIVARY GLAND ADENOID CYSTIC CARCINOMA; BIOSYNTHESIS; CELL HYPOXIA; GENETICS; HUMAN; HYPOXIA; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; SALIVARY GLAND TUMOR; TUMOR CELL LINE;

ADENOID CYSTIC CARCINOMA; HYPOXIA; VASCULAR ENDOTHELIAL GROWTH FACTOR;

CARCINOMA, ADENOID CYSTIC; CELL HYPOXIA; CELL LINE, TUMOR; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM METASTASIS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84897062137     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Spiro RH: Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg 174: 495-498, 1997.
2. Laurie SA, Ho AL, Fury MG, Sherman E and Pfister DG: Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. Lancet Oncol 12: 815-824, 2011.
3. Zhang J and Peng B: In vitro angiogenesis and expression of nuclear factor κB and VEGF in high and low metastasis cell lines of salivary gland adenoid cystic carcinoma. BMC Cancer 7: 95, 2007.
4. Ishibashi H, Shiratuchi T, Nakagawa K, Onimaru M, Sugiura T, Sueishi K and Shirasuna K: Hypoxia-induced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release. Oral Oncology 37: 77-83, 2001.
5. Choi S, Sano TD, Cheung M, Zhao M, Jasser SA, Ryan AJ, Mao L, Chen WT, El-Naggar AK and Myers JN: Vandetanib inhibits growth of adenocystic carcinoma in an orthotopic nude mouse model. Clin Cancer Res 14: 5081-5089, 2008.
6. Relf M, LeJeune S, Scott PA, Fox S, Smith K, Leek R, Moghaddam A, Whitehouse R, Bicknell R and Harris AL: Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57: 963-969, 1997.
7. Shweiki D, Itin A, Soffer D and Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
8. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
9. Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144: 646-674, 2011.
10. Lejbkowicz F, Goldberg-Cohen I and Levy AP: New horizons for VEGF. Is there a role for nuclear localization?. Acta Histochem 106: 405-411, 2005.
11. Levy AP, Levy NS and Goldberg MA: Post-transcriptional regulation of vascular endothelial growth factor gene by hypoxia. J Biol Chem 271: 2746-2753, 1996.
12. Semenza GL: HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest 123: 3664-3671, 2013.
13. 2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
14. Koh MY, Spivak-Kroizman T, Venturini S, Welsh S, Williams RR, Kirkpatrick DL and Powis G: Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxiainducible factor-1α. Mol Cancer Ther 7: 90-100, 2008.
15. Nishida T, Kondo S, Maeda A, Kubota S, Lyons KM and Takigawa M: CCN family 2/connective tissue growth factor (CCN2/CTGF) regulates the expression of vegf through hif-1α expression in a chondrocytic cell line, HCS-2/8, under hypoxic condition. Bone 44: 24-31, 2009.
16. Vered M, Braunstein E and Buchner A: Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin. Head Neck 24: 632-636, 2002.